BidaskClub upgraded shares of Trupanion (NASDAQ:TRUP) from a sell rating to a hold rating in a research note published on Friday morning.
Several other research analysts have also commented on TRUP. Zacks Investment Research lowered Trupanion from a strong-buy rating to a hold rating in a research report on Thursday, October 11th. ValuEngine lowered Trupanion from a strong-buy rating to a buy rating in a research report on Thursday, October 4th. Canaccord Genuity lifted their price target on Trupanion from $40.00 to $46.00 and gave the stock a buy rating in a research report on Friday, August 3rd. Lake Street Capital reiterated a buy rating and issued a $46.00 price target (up previously from $41.00) on shares of Trupanion in a research report on Friday, August 3rd. Finally, Stifel Nicolaus lifted their price target on Trupanion from $34.00 to $40.00 and gave the stock a buy rating in a research report on Tuesday, July 10th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Trupanion currently has an average rating of Buy and an average target price of $45.22.
Shares of Trupanion stock traded down $2.19 during trading on Friday, reaching $27.08. 900,071 shares of the stock traded hands, compared to its average volume of 583,941. The firm has a market cap of $959.90 million, a price-to-earnings ratio of -386.86 and a beta of 0.60. The company has a quick ratio of 3.04, a current ratio of 3.04 and a debt-to-equity ratio of 0.16. Trupanion has a 52-week low of $25.50 and a 52-week high of $46.70.
Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, August 2nd. The financial services provider reported ($0.01) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.04. The firm had revenue of $73.39 million during the quarter, compared to analyst estimates of $72.70 million. Trupanion had a negative return on equity of 4.43% and a negative net margin of 0.84%. The business’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same quarter last year, the business posted ($0.02) earnings per share. On average, equities analysts expect that Trupanion will post -0.08 EPS for the current fiscal year.
In other Trupanion news, insider Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, October 12th. The stock was sold at an average price of $29.04, for a total transaction of $116,160.00. Following the completion of the transaction, the insider now owns 1,277,989 shares in the company, valued at $37,112,800.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Murray B. Low sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $38.12, for a total value of $114,360.00. Following the transaction, the director now owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The disclosure for this sale can be found here. Insiders have sold 27,450 shares of company stock valued at $1,017,999 in the last 90 days. Company insiders own 20.70% of the company’s stock.
Large investors have recently made changes to their positions in the business. SG Americas Securities LLC purchased a new position in shares of Trupanion during the second quarter valued at approximately $100,000. Summit Trail Advisors LLC boosted its position in shares of Trupanion by 2,638.0% during the first quarter. Summit Trail Advisors LLC now owns 109,876 shares of the financial services provider’s stock valued at $110,000 after buying an additional 105,863 shares during the period. First Mercantile Trust Co. purchased a new position in shares of Trupanion during the second quarter valued at approximately $142,000. US Bancorp DE boosted its position in shares of Trupanion by 111.8% during the second quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock valued at $175,000 after buying an additional 2,382 shares during the period. Finally, Xact Kapitalforvaltning AB purchased a new position in shares of Trupanion during the second quarter valued at approximately $224,000. Institutional investors and hedge funds own 93.85% of the company’s stock.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Further Reading: Technical Analysis of Stocks, How Can It Help
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.